Skip to main content
Infectious Disease

Epidemiology and characteristics of cases with monkeypox virus clade I in the WHO European Region, 2024 to 2025

BACKGROUNDA public health emergency of international concern (PHEIC) was declared in August 2024 following a sharp increase in mpox cases linked to the emergence of monkeypox virus (MPXV) clade Ib.AIMWe aimed to characterise imported and locally acquired mpox clade I cases report

EC
EuroClinics Editorial 9 July 2026
2 min read 354 words
BACKGROUNDA public health emergency of international concern (PHEIC) was declared in August 2024 following a sharp increase in mpox cases linked to the emergence of monkeypox virus (MPXV) clade Ib.AIMWe aimed to characterise imported and locally acquired mpox clade I cases reported in the WHO European Region (WHO/Europe) since August 2024 and assess transmission patterns and response measures.METHODSWe collected data on MPXV clade I infections reported by countries in WHO/Europe through the International Health Regulations. We contacted reporting countries to collect age, sex, travel history, most likely route of transmission, clinical course, contacts and type of exposure, and implemented control and prevention measures.RESULTSBetween 14 August 2024 and 23 November 2025, 82 cases of MPXV clade I infection were reported; 45 were imported and 37 were infected in reporting countries. Seventy-nine were typed as clade Ib and two as clade Ia. Most imported cases reported heterosexual (n = 26) or close physical contact (n = 5) as possible exposure. Secondary transmission occurred in six households. One healthcare worker was infected. Since October 2025, further 17 autochthonous male cases were most likely infected through sex with other men.CONCLUSIONImported cases of MPXV clade I infection were associated with limited household transmission. The increase in autochthonous infections among men with recent sexual contact with other men suggests undetected spread in Europe, that may become sustained. Continued surveillance, case and contact investigation are needed to understand MPXV clade I epidemiology and drivers of MPXV clade I transmission in Europe.

Auteur(s) : Karagiannis Ioannis, Pires Jeffrey, Akhmetniyaz Pana, le Polain de Waroux Olivier, Hoorelbeke Bart, Gagnière Bertrand, Jansen Klaus, Tsiara Chrysa, Igoe Derval, Campitiello Maria Rosaria, van Ewijk Catharina, Cabral Veríssimo Vítor, Santos Larrégola Laura, Sturegård Erik, Gardiol Céline, Karakök Taliha, Hughes Gareth J, Widdowson Marc-Alain

Année de publication : 2026

Pages : 31-38

Site web de l'éditeur

En relation avec

Nos dernières actualités

actualité

10 juillet 2026

Se baigner en toute sécurité en adoptant les bons gestes

actualité

9 juillet 2026

Santé publique France publie son Rapport annuel 2025 : 10 ans d’engagement...

actualité

3 juillet 2026

Point de situation sur la mortalité toutes causes confondues sur la période...

EC

EuroClinics Editorial

Patient-facing healthcare guidance

Our editorial team distils the latest from European medical authorities (WHO Europe, ECDC, EMA, NHS, AEMPS, HAS) into plain-language guides for patients. Every article is reviewed against authoritative sources.

🏥

Need infectious disease in Europe?

Browse verified clinics with transparent pricing and real reviews across 30+ countries.

Find a clinic →
Source. Santé publique France — Santé publique France, sous licence ouverte 2.0
Medical disclaimer. Articles are general information aggregated from third-party medical sources. They are NOT a substitute for in-person diagnosis or treatment. For personal medical guidance, consult a verified clinician or call your local emergency line (112 in the EU).

Browse the directory →